日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Clinical outcomes with perioperative nivolumab by nodal status in patients with stage III resectable NSCLC: phase 3 CheckMate 77T exploratory analysis

III期可切除非小细胞肺癌患者围手术期接受纳武利尤单抗治疗的临床结局与淋巴结状态的关系:CheckMate 77T III期探索性分析

Provencio, Mariano; Awad, Mark M; Spicer, Jonathan D; Janssens, Annelies; Moiseyenko, Fedor; Gao, Yang; Watanabe, Yasutaka; Alexandru, Aurelia; Guisier, Florian; Frost, Nikolaj; Franke, Fabio; Hiltermann, T Jeroen Nicolaas; He, Jie; Tanaka, Fumihiro; Lu, Shun; Coronado Erdmann, Cinthya; Sathyanarayana, Padma; Tran, Phuong; Devas, Vipul; Cascone, Tina

Bridging the lung cancer screening eligibility gap: evaluation of guideline applicability in asymptomatic patients

弥合肺癌筛查资格差距:评估指南在无症状患者中的适用性

Wang, Chen-Ran; Li, Ren-Da; Wang, Pan; Dong, Xue-Si; Zhang, Hao; Zeng, Qing-Peng; Xie, Jia-Xin; Luo, Zi-Lin; Chen, Xiao-Lu; Zheng, Ya-Di; Li, Ji-Bin; Xu, Yong-Jie; Wang, Fei; Li, Ni; Tan, Feng-Wei; He, Jie

The role of artificial intelligence in advancing population-based cancer registration

人工智能在推进基于人群的癌症登记中的作用

Ding, Shuai; Liu, Mingyuan; Wang, Hao; Song, Cheng; Zhao, Luyue; Yang, Zhihao; Wang, Yue; Wang, Yifan; Cui, Haitao; Liu, Zihao; Liu, Dongrun; Matsuda, Tomohiro; Hori, Megumi; Katsimpokis, Dimitris; Geleijnse, Gijs; Farré, Xavier; Morrison, David S; Wang, Yaogang; Zhang, Siwei; Liu, Meicen; Geng, Qiushuo; Ni, Ling; Sun, Kexin; Han, Bingfeng; Wang, Shaoming; Chen, Ru; Li, Li; Sugiyama, Hiromi; Jung, Kyu-Won; Wei, Yongyue; Chen, Wanqing; Soerjomataram, Isabelle; Bray, Freddie; Zeng, Hongmei; He, Jie

Lymph Node Dissection Guideline Adherence and Survival in Patients With T1N0M0 Lung Adenocarcinoma

T1N0M0期肺腺癌患者淋巴结清扫指南的依从性与生存率

Li, Renda; Wang, Pan; Zhang, Hao; Zeng, Qingpeng; Wang, Chenran; Li, Ni; Yang, Wenjing; Tan, Fengwei; He, Jie

Osteoclast-Derived SLIT3 Mediates Osteoarthritis Pain and Degenerative Changes.

破骨细胞衍生的 SLIT3 介导骨关节炎疼痛和退行性改变。

Zhu Weiwei, Qin Wenpin, Gao Jialu, Guo Yihan, Han Xiaoxiao, Ma Zhangyu, Zhang Xiaokang, He Jie, Liu Jing, Gao Bo, Li Changjun, Niu Lina, Yan Jianfei, Jiao Kai

LPS-induced structural reorganization and polymerization drive noncanonical inflammasome activation

LPS诱导的结构重组和聚合驱动非经典炎症小体激活。

Wang, Chengliang; Lacey, Philip; Tian, Tian; Teran, Evelyn; Liaqat, Maham; Shivcharan, Sonia; Shumba, Patience; He, Jie; Rathinam, Vijay A; Wysocki, Vicki H; Ruan, Jianbin

Clinical Benefit of PD-1/PD-L1 Inhibitors as Standard First-Line Treatment in Low PD-L1-Expressing Advanced Solid Tumors: A Systematic Review and Meta-Analysis

PD-1/PD-L1抑制剂作为PD-L1低表达晚期实体瘤一线标准治疗的临床获益:系统评价和荟萃分析

Wu, Peng; Gu, Xuanyu; Li, Dongyu; Zi, Xiaohui; Shang, Dexin; Liu, Jingjing; Ma, Ruijie; Peng, Jilin; Zhang, Guochao; Che, Yun; Zeng, Qingpeng; Zhao, Bohui; Sun, Nan; Zhang, Chaoqi; He, Jie

Inhibiting ADAR1-Mediated Excessive Epigenetic A-to-I RNA Editing Improves the Immune Microenvironment and Increases Sensitivity to Immunotherapy in Lung Adenocarcinoma

抑制ADAR1介导的过度表观遗传A-to-I RNA编辑可改善免疫微环境并提高肺腺癌对免疫疗法的敏感性

Wang, Sihui; Zheng, Sufei; Liu, Chengming; Zhang, Chaoqi; Wang, Xinfeng; Wang, Zhanyu; Wang, Yan; Feng, Xiaoli; Xue, Qi; Sun, Nan; He, Jie

Prognostic Implications of Programmed Cell Death Ligand 1 Expression, Cluster of Differentiation 8-Positive T-Cell Infiltration, and Related Immunophenotypes in Invasive Mucinous Adenocarcinoma of the Lung: A Multicenter Study

程序性死亡配体1表达、CD8阳性T细胞浸润及相关免疫表型在肺浸润性黏液腺癌中的预后意义:一项多中心研究

Zhang, Guochao; Zheng, Chao; Jia, Jia; Li, Xingchen; Wang, Lide; Zhang, Long; Zhang, Yuzhuo; Yue, Meng; Zhang, Shuangping; Liu, Yueping; Xue, Liyan; Xue, Qi; He, Jie

Validation and refinement of the AJCC 8th edition ypStage in esophageal squamous cell carcinoma after neoadjuvant therapy: a large-scale retrospective cohort study

新辅助治疗后食管鳞状细胞癌AJCC第8版yp分期的验证和完善:一项大规模回顾性队列研究

Liu, Zhiqiang; Chen, Xiankai; Wei, Xiufeng; Qin, Jianjun; Li, Yong; Wang, Zhen; Shang, Xiaobin; Huang, Zhendong; Meng, Fanmao; Xie, Shao-Hua; He, Jie; Kang, Xiaozheng; Zhang, Ruixiang; Li, Yin